Final answer:
Cystic hydatid disease caused by Echinococcus granulosus is treated with albendazole, particularly for adults weighing over 60kg. Dosage depends on several factors including the severity of infection, patient's weight, and number.
Step-by-step explanation:
Cystic hydatid disease, also known as cystic echinococcosis, is an infection caused by the tapeworm Echinococcus granulosus. This parasitic disease primarily affects the liver, lung, and peritoneum, where it can form hydatid cysts. These cysts are typically detected using imaging techniques such as ultrasonography, CT, or MRI, and may be discovered due to serologic tests including ELISA and indirect hemagglutinin tests. Albendazole is a key anti-helminthic drug used in chemotherapy treatment, particularly for adults weighing over 60kg with this condition.
The standard treatment involves surgically removing the cysts when feasible, but in instances where surgery is not the preferred option, or as an adjunct to surgery, albendazole is prescribed. Albendazole use in the treatment of cystic hydatid disease works by inhibiting parasite growth and preventing the spread of infection. However, dosing for cystic hydatid disease can vary depending on the severity of the infection, the number of cysts, and the patient's response to the drug.
It is essential for medical professionals to determine the appropriate dosing of albendazole for each patient. In adults >60kg, the dosing will be adjusted according to the individual's weight and clinical condition. Usually, a higher dose is required for larger or multiple cysts, and for heavier patients, under close medical supervision. Treatment may be prolonged, involving multiple courses of therapy, and it is often combined with corticosteroids to decrease the inflammation caused by parasite death.